Get App Open
In App
Lending
Lending
Open App
you are here:

Sun Pharma Advanced Research Company Ltd.

BSE: 532872 | NSE: SPARC |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE232I01014 | SECTOR: Biotechnology & Medical Research

BSE Live

Oct 31, 16:01
134.90 -2.15 (-1.57%)
Volume
AVERAGE VOLUME
5-Day
163,506
10-Day
90,854
30-Day
47,911
19,891
  • Prev. Close

    137.05

  • Open Price

    136.00

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Oct 31, 15:59
135.19 -1.76 (-1.29%)
Volume
AVERAGE VOLUME
5-Day
1,827,641
10-Day
997,995
30-Day
520,847
198,988
  • Prev. Close

    136.95

  • Open Price

    136.09

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    135.19 (1878)

Company Facts - Sun Pharma Advanced Research Company

Registered Address

Plot No. 5 & 6/1, Savli G.I.D.C. Estate,
Savli - Vadodara Highway,,Manjusar,
Vadodra District
Gujarat
391775

Tel: 02667-666800
Fax: 02667-
Email: secretarial@sparcmail.com
Website: http://www.sparc.life
Group: Not Applicable

Registrars

MUFG Intime India Pvt. Ltd. C 101, 247 Park, L.B.S. Marg, Vikhroli (West),
Mumbai - 400083
Maharashtra

Tel: 022-49186270, 49186200
Fax: 022-49186060
Email: rnt.helpdesk@linkintime.co.in
Website: http://www.linkintime.co.in

Management - Sun Pharma Advanced Research Company

NameDesignation
Dilip S Shanghvi Chairman & Non-Exe.Director
Vidhi Shanghvi Non Executive Director
Bhavna Doshi Independent Director
Robert J Spiegel Independent Director
NameDesignation
T Rajamannar Non Executive Director
Venkateswarlu Jasti Independent Director
Ferzaan Engineer Independent Director
Rekha Warriar Independent Director
Source : Dion Global Solutions Limited
Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347